“The ‘AA’ rating reflects our view of Texas Health’s operating results and good pro forma maximum annual debt service coverage of 4.4 times in fiscal 2016, excellent operational liquidity of over 400 days’ cash on hand on a pro forma basis, leading market share in the rapidly growing Dallas-Fort Worth metropolitan area marketplace and highly capable management team,” said S&P analyst Kevin Holloran.
The outlook is stable, reflecting S&P’s anticipation that Texas Health Resources will continue its track record of solid operations.
More articles on healthcare finance:
For-profit hospital stock report: Week of Sept. 19-23
Mount Sinai VP talks cost, burden of RAC audit uptick
S&P raises Palomar Health’s ratings to ‘A’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
